We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
bioAffinity Technologies Inc | NASDAQ:BIAF | NASDAQ | Common Stock |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.11 | 5.58% | 2.08 | 2.08 | 2.24 | 2.11 | 1.93 | 1.96 | 87,405 | 00:15:22 |
FORM 4
[ ]
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 |
OMB APPROVAL
OMB Number: 3235-0287 Estimated average burden hours per response... 0.5 |
| |
1. Name and Address of Reporting Person * GIRGENTI STEVEN | 2. Issuer Name and Ticker or Trading Symbol bioAffinity Technologies, Inc. [ BIAF ] |
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
__X__ Director _____ 10% Owner __X__ Officer (give title below) _____ Other (specify below) Executive Chairman |
3. Date of Earliest Transaction
(MM/DD/YYYY)
| ||
4. If Amendment, Date Original Filed
(MM/DD/YYYY)
|
6. Individual or Joint/Group Filing
(Check Applicable Line)
_X
_ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person |
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned | ||||||||||
1.Title of Security (Instr. 3) | 2. Trans. Date | 2A. Deemed Execution Date, if any |
3. Trans. Code (Instr. 8) |
4. Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) |
5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) | 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) | 7. Nature of Indirect Beneficial Ownership (Instr. 4) | |||
Code | V | Amount | (A) or (D) | Price | ||||||
Common Stock (1) | 9/6/2022 | C | 7657 (3) | A | $4.20 (3) | 7657 | I | By Trust (2) | ||
Common Stock (1) | 9/6/2022 | C | 156602 (4) | A | $4.20 (4) | 405880 | D | |||
Common Stock (1) | 9/6/2022 | C | 7657 (5) | A | $4.20 (5) | 413537 | D | |||
Common Stock (1) | 9/6/2022 | C | 59141 (6) | A | $4.20 (6) | 472678 | D | |||
Common Stock (1) | 9/6/2022 | C | 58797 (7) | A | $4.20 (7) | 531475 | D | |||
Common Stock (1) | 9/6/2022 | C | 27378 (8) | A | $4.20 (8) | 558853 | D | |||
Common Stock (1) | 9/6/2022 | C | 4912 (9) | A | $4.20 (9) | 563765 | D | |||
Common Stock (1) | 9/6/2022 | C | 2694 (10) | A | $4.20 (10) | 566459 | D | |||
Common Stock (1) | 9/6/2022 | C | 13326 (11) | A | $4.20 (11) | 579785 | D | |||
Common Stock (1) | 9/6/2022 | C | 10632 (12) | A | $4.20 (12) | 590417 | D | |||
Common Stock (1) | 9/6/2022 | C | 39275 (13) | A | $4.20 (13) | 629692 | D | |||
Common Stock (1) | 9/6/2022 | C | 15632 (14) | A | $4.20 (14) | 645324 | D | |||
Common Stock (1) | 9/6/2022 | C | 35866 (15) | A | $4.20 (15) | 681190 | D | |||
Common Stock (1) | 9/6/2022 | C | 138993 (16) | A | $3.60 (16) | 820183 | D | |||
Common Stock (1) | 9/6/2022 | C | 1298 (17) | A | $7.70 (17) | 8955 | I | By Trust (2) | ||
Common Stock (1) | 8/31/2022 | P | 40916 | A | (18) | 861099 | D |
Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities) | |||||||||||||||
1. Title of Derivate Security (Instr. 3) | 2. Conversion or Exercise Price of Derivative Security | 3. Trans. Date | 3A. Deemed Execution Date, if any | 4. Trans. Code (Instr. 8) | 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) | 6. Date Exercisable and Expiration Date | 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) | 8. Price of Derivative Security (Instr. 5) | 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) | 10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4) | 11. Nature of Indirect Beneficial Ownership (Instr. 4) | ||||
Code | V | (A) | (D) | Date Exercisable | Expiration Date | Title | Amount or Number of Shares | ||||||||
Secured Convertible Promissory Note (1) | $4.20 (3) | 9/6/2022 | C | $32161.64 | 9/6/2022 (3) | 10/31/2022 | Common Stock | 7657 | $0 | 0 | I | By Trust (2) | |||
Secured Convertible Promissory Note (1) | $4.20 (4) | 9/6/2022 | C | $657731.96 | 9/6/2022 (4) | 10/31/2022 | Common Stock | 156602 | $0 | 0 | D | ||||
Secured Convertible Promissory Note (1) | $4.20 (5) | 9/6/2022 | C | $32161.64 | 9/6/2022 (5) | 10/31/2022 | Common Stock | 7657 | $0 | 0 | D | ||||
Secured Convertible Promissory Note (1) | $4.20 (6) | 9/6/2022 | C | $248394.52 | 9/6/2022 (6) | 10/31/2022 | Common Stock | 59141 | $0 | 0 | D | ||||
Secured Convertible Promissory Note (1) | $4.20 (7) | 9/6/2022 | C | $246947.95 | 9/6/2022 (7) | 10/31/2022 | Common Stock | 58797 | $0 | 0 | D | ||||
Unsecured Convertible Promissory Note (1) | $4.20 (8) | 9/6/2022 | C | $114991.78 | 9/6/2022 (8) | 10/31/2022 | Common Stock | 27378 | $0 | 0 | D | ||||
Unsecured Convertible Promissory Note (1) | $4.20 (9) | 9/6/2022 | C | $20633.60 | 9/6/2022 (9) | 10/31/2022 | Common Stock | 4912 | $0 | 0 | D | ||||
Unsecured Convertible Promissory Note (1) | $4.20 (10) | 9/6/2022 | C | $11317.26 | 9/6/2022 (10) | 10/31/2022 | Common Stock | 2694 | $0 | 0 | D | ||||
Unsecured Convertible Promissory Note (1) | $4.20 (11) | 9/6/2022 | C | $55972.60 | 9/6/2022 (11) | 10/31/2022 | Common Stock | 13326 | $0 | 0 | D | ||||
Unsecured Convertible Promissory Note (1) | $4.20 (12) | 9/6/2022 | C | $44655.34 | 9/6/2022 (12) | 10/31/2022 | Common Stock | 10632 | $0 | 0 | D | ||||
Unsecured Convertible Promissory Note (1) | $4.20 (13) | 9/6/2022 | C | $164958.90 | 9/6/2022 (13) | 10/31/2022 | Common Stock | 39275 | $0 | 0 | D | ||||
Unsecured Convertible Promissory Note (1) | $4.20 (14) | 9/6/2022 | C | $65654.79 | 9/6/2022 (14) | 12/31/2022 | Common Stock | 15632 | $0 | 0 | D | ||||
Unsecured Convertible Promissory Note (1) | $4.20 (15) | 9/6/2022 | C | $150641.10 | 9/6/2022 (15) | 10/31/2022 | Common Stock | 35866 | $0 | 0 | D | ||||
Series A Convertible Preferred Stock (1) | $3.60 (16) | 9/6/2022 | C | 972957 | (16) | (16) | Common Stock | 138993 | $0 | 0 | D | ||||
Series A Convertible Preferred Stock (1) | $7.70 (17) | 9/6/2022 | C | 9091 | (17) | (17) | Common Stock | 1298 | $0 | 0 | I | By Trust (2) | |||
Warrants (right to buy) (1) | $7.35 (18) | 8/31/2022 | P | 40916 | 8/31/2022 | 8/31/2027 | Common Stock | 40916 | (18) | 40916 | D | ||||
Non-tradeable Warrants (right to buy) (1) | $7.656 (18) | 8/31/2022 | P | 40916 | 8/31/2022 | 8/31/2027 | Common Stock | 40916 | (18) | 40916 | D | ||||
Warrants (right to buy) (1) | $6.125 (19) | 9/6/2022 | A | 221933 (19) | 9/6/2022 (19) | 8/25/2026 | Common Stock | 221933 | (19) | 221933 | D | ||||
Warrants (right to buy) (1) | $6.125 (20) | 9/6/2022 | P | 5952 | 9/6/2022 (20) | 8/25/2026 | Common Stock | 5952 | (20) | 5952 | I | By Trust (2) | |||
Warrants (right to buy) (1) | $6.125 (21) | 9/6/2022 | A | 87605 (21) | 9/6/2022 (21) | 12/2/2026 | Common Stock | 87605 | (21) | 87605 | D | ||||
Warrants (right to buy) (1) | $6.125 (22) | 9/6/2022 | A | 35714 | 9/6/2022 (22) | 8/11/2027 | Common Stock | 35714 | (22) | 35714 | D | ||||
Warrants (right to buy) (1) | $5.25 | 7/20/2022 | A | 123811 (23) | 7/20/2022 | 7/20/2027 | Common Stock | 123811 | (23) | 123811 | D | ||||
Warrants (right to buy) (1) | $5.25 | 7/20/2022 | P | 2380 | 7/20/2022 | 7/20/2027 | Common Stock | 2380 | (24) | 2380 | I | By Trust (2) |
Remarks: Exhibit 24.1: Power of Attorney (Steven Girgenti) |
Reporting Owners | |||||
Reporting Owner Name / Address | |||||
Director | 10% Owner | Officer | Other | ||
GIRGENTI STEVEN 3312 JUDITH DRIVE BELLMORE, NY 11710 | X | Executive Chairman |
Signatures | ||
/s/ Wilhelm E. Liebmann, as attorney-in-fact for Steven Girgenti | 11/7/2022 | |
**Signature of Reporting Person | Date |
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly. | |
* | If the form is filed by more than one reporting person, see Instruction 4(b)(v). |
** | Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a). |
Note: | File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure. |
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number. |
1 Year bioAffinity Technologies Chart |
1 Month bioAffinity Technologies Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions